Claims
- 1. A compound represented by the formula
- 2. A compound according to claim 1 wherein L is CH2CH3, X is —S—, R1 is CH3 and R2 and Rp are as defined in claim 1.
- 3. A compound according to claim 1 which is selected from the group consisting of:
Compound of formula (1): L=CH2CH3, X=S, R1=CH3, R2=2-[6-(dimethylamino-methyleneamino)purin-9-yl]-ethyl and Rp=H; Compound of formula (1): L=CH2CH3, X=S, R1=CH3, R2=2-(6-amino-purin-yl)-ethyl and Rp=H; Compound of formula (1): L=CH2CH3, X=S, R1=CH3, R2=3-(3-pyridinyl)-1H-pyrazole-ethyl and Rp=H; Compound of formula (1): L=CH2CH3, X=S, R1=CH3, R2=[3-(3-pyridinyl)-1H-1,2,4-triazole-1-yl]-ethyl and Rp=H; Compound of formula (1): L=CH2CH3, X=S, R1=CH3, R2==[4(3-pyridinyl)-1H-imidazole]-1-ethyl and Rp=H; and Compound of formula (I): L=CH2CH3, X=0, R1=CH3, R2=CH2CH2-phenyl and Rp=H.
- 4. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1, or a pharmaceutically-acceptable salt, ester or prodrug thereof, in combination with a pharmaceutically acceptable carrier.
- 5. A method for controlling a bacterial infection in an animal comprising administering to an animal a therapeutically-effective amount of a pharmaceutical composition according to claim 4.
- 6. A process for preparing a compound represented by the formula
REFERENCE TO RELATED APPLICATION
[0001] This application is a continuation of application Ser. No. 10/289,820 (filed Nov. 7, 2002), which is incorporated herein by reference in its entirety.
Continuations (1)
|
Number |
Date |
Country |
Parent |
10289820 |
Nov 2002 |
US |
Child |
10812501 |
Mar 2004 |
US |